145 results on '"Fatoye C"'
Search Results
2. MSR103 Translation, Cultural Adaptation, and Psychometric Testing of the Hip Disability and Osteoarthritis Outcome Score Into Yoruba Language
3. MSR37 Validation of the Ibadan Knee/Hip Osteoarthritis Outcome Measure (IKHOAM) Among Patients With Knee Osteoarthritis
4. Cross-cultural adaptation and psychometric evaluation of the Yoruba version of the Back beliefs questionnaire among patients with chronic low-back pain
5. Missed Physiotherapy Appointment and Its Influence on Cost, Efficiency and Patients' Outcomes.
6. Real-world effectiveness and costs of vertical oscillatory pressure manipulation for low back pain
7. MSR103 Translation, Cultural Adaptation, and Psychometric Testing of the Hip Disability and Osteoarthritis Outcome Score Into Yoruba Language
8. MSR37 Validation of the Ibadan Knee/Hip Osteoarthritis Outcome Measure (IKHOAM) Among Patients With Knee Osteoarthritis
9. HSD71 Convergent and Known-Group Validity of the Start Musculoskeletal Tool Among Patients with Neck Pain
10. EE23 Translation, Cross-Cultural Adaptation and Psychometric Testing of a Yoruba Version of the EQ-5D Questionnaire in Patients with Musculoskeletal Disorders
11. Translation, cross-cultural adaptation and psychometric testing of a Yoruba version of the EQ-5D Questionnaire in patients with musculoskeletal disorders
12. Clinical and Cost Effectiveness of a Clinic-Based and Two Digital Applications of Mckenzie Therapy for Chronic Low-Back Pain
13. PCR174 Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
14. HSD6 The Role of Market Access Professionals in Pharmaceutical Industry: Document Analysis
15. EPH157 Does COVID-19 Related Lockdown Restrictions Impact People With Musculoskeletal Disorders? A Systematic Review
16. POSC72 Clinical and Cost Effectiveness of a Clinic-Based and Two Digital Applications of McKenzie Therapy for Chronic Low-Back Pain
17. Validation of the Yoruba Version of the Pain Self-Efficacy Questionnaire in patients with chronic low back pain
18. Awareness, attitude and expectations of physiotherapy students on telerehabilitation
19. Translation, cross-cultural adaptation and psychometric evaluation of Yoruba version of the short-form 12 health survey
20. PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria
21. Development and Feasibility Testing of a Mobile-Phone Application for Exercise in Non-Specific Long-Term Low-Back Pain
22. PNS228 The Effect of Disability on Daily Living Tasks
23. PNS226 The Role of Patients in the Uptake of Pharmaceutical Products: A Qualitative Study
24. PIH6 Pattern and Determinants of Willingness to Pay for Antenatal and Postnatal Physiotherapy in Nigeria
25. PNS260 Problems Experienced By Involving Patients at Post-Launch STAGE of Pharmaceutical Product Development
26. PMU11 Evaluation of Missed Physiotherapy Appointment and Its Influence on Cost, Efficiency and Patient Outcomes
27. PMS30 Real World Prevalence, Pattern and Cost of Physiotherapy Treatment for Osteoarthritis in Nigeria
28. PMS19 A SYSTEMATIC REVIEW OF ECONOMIC MODELS FOR COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION FOLLOWING TOTAL KNEE AND HIP REPLACEMENT
29. PMS20 COST EFFECTIVENESS OF VIRTUAL REALITY GAME VERSUS CLINIC BASED MCKENZIE EXTENSION THERAPY FOR CHRONIC NON SPECIFIC LOW BACK PAIN
30. PNS186 THE ROLE OF MARKET ACCESS (MA) AND HEALTH ECONOMIC AND OUTCOMES RESEARCH (HEOR) PROFESSIONALS IN THE UPTAKE OF PHARMACEUTICAL PRODUCTS BY PATIENTS: THEMATIC ANALYSES OF QUALITATIVE STUDY
31. PNS197 FACTORS ENSURING SUCCESSFUL UPTAKE OF PHARMACEUTICAL PRODUCTS BY PATIENTS: THEMATIC ANALYSES OF QUALITATIVE STUDY
32. PMS41 THE ECONOMIC BURDEN OF MUSCULOSKELETAL DISORDERS RESULTING FROM ROAD TRAFIC ACCIDENT IN LOW AND MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW
33. Back Beliefs Questionnaire--Yoruba Version
34. Cultural adaptation and psychometric evaluation of the Yoruba version of the Health Literacy Questionnaire.
35. The effectiveness of personalisation on health outcomes of older people: A systematic review
36. PNS402 PERCEIVED BARRIERS TO ENSURING THE EFFECTIVE UPTAKE OF PHARMACEUTICAL PRODUCTS BY PATIENTS
37. PNS355 HOW INVOLVED SHOULD PAYERS BE IN THE DEVELOPMENTS OF TARGET PRODUCT PROFILE (TPP), PRODUCT DEVELOPMENT PLAN (PDP) AND DESIGN OF CLINICAL TRIALS (DOCT)
38. PNS357 HOW TO RESOLVE ISSUES EXPERIENCED BY PAYERS FOR THEIR INVOLVEMENT AT PRE-LAUNCH STAGE
39. PNS354 MARKET ACCESS AS DEFINED BY MARKET ACCESS (MA), HEALTH ECONOMICS, AND OUTCOMES RESEARCH (HEOR) PROFESSIONALS
40. PNS351 ROLE OF MARKET ACCESS (MA), AND HEALTH ECONOMIC AND OUTCOMES RESEARCH (HEOR) PROFESSIONALS IN THE UPTAKE OF PHARMACEUTICAL PRODUCTS.
41. PNS80 COST-EFFECTIVENESS ANALYSES OF PERSONALISATION/HOME CARE FOR OLDER PEOPLE COMPARED TO NURSING HOME CARE: A SYSTEMATIC REVIEW
42. PNS356 PAYERS RELATED ISSUES ARISING FROM THE DEVELOPMENT OF PHARMACEUTICAL PRODUCTS AT PRE-LAUNCH
43. PMS59 REAL-WORLD EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTIONS FOR MUSCULOSKELETAL DISORDERS IN NIGERIA
44. PNS392 THE ROLE OF PATIENTS IN THE UPTAKE OF PHARMACEUTICAL PRODUCTS BY PATIENTS AS PERCEIVED BY PROFESSIONALS
45. PNS248 THE INVOLVEMENT OF PATIENTS IN THE REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS
46. PNS149 THE MEDICAL AND SOCIAL MODELS OF DISABILITY.
47. PNS150 DISABILITY AS DEFINED BY MARKET ACCESS AND HEALTH ECONOMICS AND OUTCOMES RESEARCH PROFESSIONALS: MIXED METHODS.
48. PNS255 PATIENTS RELATED ISSUES ARISING FROM REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS
49. PNS256 HOW TO RESOLVE PROBLEMS EXPERIENCED WITH REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS WHEN PATIENTS ARE INVOLVED
50. PNS148 EDUCATING PUBLIC ABOUT DISABILITY AND GIVING PEOPLE WITH DISABILITY THE SAME OPPORTUNITY AS PEOPLE WITHOUT DISABILITY: DESCRIPTIVE ANALYSIS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.